Summary:
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses versus Placebo in Patients with Type 2 Diabetes on Metformin Monotherapy
Qualified Participants Must:
• Be diagnosed with Type 2 diabtes
•
Be on a stabel dose of Metformin monotherapy
Qualified Participants May Receive:
Study related care and possibility of reimbursemnet for time and travel